Brand Connect
Commercial solution reinforcing brand touchpoints throughout patient treatment journey
Platform · Cloud SaaSCompany source
Company profile
About SubjectWell
SubjectWell is a clinical trial patient recruitment and site enablement company that operates the SubjectWell+ platform to connect patients with clinical trials and new treatment options. The company addresses the clinical trial industry's 80% failure rate by providing comprehensive patient recruitment solutions powered by a Patient Network of over 15 million patients, advanced technology, and extensive partner networks. SubjectWell serves sponsors, CROs, clinical trial sites, site networks, and pharmaceutical brand marketers with flexible, tiered solutions ranging from Study Connect for patient recruitment to Brand Connect for commercial patient engagement. The company has completed over 1,500 studies across 15,000+ sites, supporting more than 500,000 patient referrals in 102 countries. SubjectWell's services include Full-Site Support with clinically-trained, multilingual Patient Companions operating across 36 countries in 22 languages, medical records retrieval, patient communication, transportation logistics, and virtual waiting room services. The platform covers over 400 therapeutic areas including rare diseases, oncology, chronic conditions, and vaccine studies. SubjectWell's mission centers on reducing site and patient burden while accelerating enrollment timelines and improving study outcomes through patient-centric recruitment strategies and comprehensive administrative support services.
Company description SubjectWell official website
Primary marketClinical Trials & Research
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at SubjectWell?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- Autoimmune disorders
- Autosomal dominant polycystic kidney disease
- Cardiovascular disease
- Chronic conditions
- Dermatology
- Endocrinology
- GLP-1 related conditions
- Idiopathic gastroparesis
- Mental health
- Musculoskeletal conditions
- Nephrology
- Neurology
- Oncology
- Ophthalmology
- Rare diseases
- Respiratory disease
- Urology
- Vaccine studies
- Women's health
Who it serves
- Agencies
- Clinical trial sites
- CROs
- Medical device companies
- Pharmaceutical brand marketers
- Site networks
- Sponsors
Deployment & integration
Cloud Saas · Other deployment with recorded integration context.
Geographic context
Markets102 countries for patient recruitment · 36 countries with Patient Companion services · Global operations · United States
Company sourceOfficial website
Company milestones
Platform expansion
Launch of OneView Portal to transform and streamline patient recruitment. Clariness announced Jim Corrigan as CEO to lead next phase of growth (March 2026).
Partnerships
Recorded partners
- Extensive partner network (unspecified)
- Media network partners
- Site networks
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
Direct Connect
Direct patient recruitment and engagement solution
Platform · Cloud SaaSCompany source
Full-Site Support
Comprehensive service for relieving site burden with multilingual Patient Companions
Service · OtherCompany source
OneView Portal
Portal to transform and streamline patient recruitment
Platform · Cloud SaaSCompany source
Patient Care & Trial Retention
End-to-end support for patients throughout the clinical trial process
Service · OtherCompany source
Recruitment Simulation
Gather insights to improve patient experience during recruitment
Software · Cloud SaaSCompany source
Secondary Screening
Reduces site effort by having Patient Companions schedule screening calls
Service · OtherCompany source
Study Connect
Proven patient recruitment solution with three flexible tiers for clinical studies
Platform · Cloud SaaSCompany source
SubjectWell+ Platform
Comprehensive patient recruitment and site enablement platform with commercial capabilities
Platform · Cloud SaaSCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Real-World Evidence Shows Gaps in Awareness, Medical Help-Seeking, and Diagnosis for Primary Dysmenorrhea but Not Premenstrual Syndrome: Cross-Sectional Observational Study.Journal of medical Internet research · Sep 11, 2025
Feasibility of a virtual, prospective real-world data study in acute rhinosinusitis.Postgraduate medicine · Sep 1, 2025
Efficient Online Recruitment of Patients With Depressive Symptoms Using Social Media: Cross-Sectional Observational Study.JMIR mental health · Jun 3, 2025
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
30% acceleration in enrollment time
Patient recruitment across clinical trials
$40 billion in recoupable losses
Industry-wide clinical trial failures addressed
500,000+ patient referrals
Across 15,000+ sites globally
9.7x faster patient progressions
Full-Site Support service with $754,000 savings
CRO - Idiopathic Gastroparesis Phase II Study
Targeted patient recruitment for Idiopathic Gastroparesis Phase II study across 70 sites
34 randomized patients recruited across 70 sites in 5 months
Rare Kidney Disease Phase III Study
Global patient recruitment for rare disease Phase III Autosomal Dominant Polycystic Kidney Disease study
Full-Site Support Implementation
Accelerating patient enrollment with Full-Site Support services
9.7x faster patient progressions, $754,000 in savings, dramatically reduced site burden
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
Jim Corrigan
CEO
06 · Company updates
Updates from SubjectWell
Recent articles published on SubjectWell's official website.
Clariness Announces Jim Corrigan as CEO to Lead Next Phase of Growth
Read on SubjectWellWhy site burden benchmarking matters
Read on SubjectWellHow global standards of care data shape patient recruitment
Read on SubjectWellGlobal Patient Recruitment Program for a Rare Kidney Disease
Read on SubjectWellRare disease trials don’t need better recruitment. They need awareness.
Read on SubjectWell07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Clinical Trials & Research
Companies using AI to optimize clinical trial design, accelerate patient recruitment, match patients to trials, predict trial outcomes, or improve clinical research efficiency. Includes patient enrollment and screening platforms, AI-powered trial matching, and tools that reduce the time and cost of bringing new treatments to market.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.